Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Response from CEO, CHAI about the Quick Start program in November 2016
Response from CEO, CHAI about the Quick Start program in November 2016
Please click here
December 21, 2016
/
News
Share
the Post
Related
Posts
Part 2: How is hepatitis C treated?
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Support letter for inclusion of Daclatasvir on 4th March, 2015.
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
Pricing of Indian generic sofosbuvir, 30th Jan,2016
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
